SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA: total counts of yeasts and molds are out of specification
Brand(s)
Last updated
Summary
Product
SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Jamp Senna |
SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA |
NPN 80009595 |
Tablet |
Sennoside A&B 8.6 mg |
2A02B3015 |
Issue
The combined total counts of yeasts and molds are out of specification in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Jamp Pharma Corporation
1310 rue Nobel,
Boucherville, Quebec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76913
Get notified
Receive notifications for new and updated recalls and alerts by category.